Current practice of insulin pump therapy in children and adolescents – the Hannover recipe
Corresponding Author
Thomas Danne
Diabeteszentrum für Kinder und Jugendliche, Kinderkrankenhaus auf der Bult, Janusz-Korczak-Allee, Hannover, Germany; and
*Thomas Danne, MD, Kinderkrankenhaus auf der Bult, Janusz-Korczak-Allee 12, D-30173, Hannover, Germany. Tel: +49-511-8115340; fax: +49-511-8115344; e-mail: [email protected]Search for more papers by this authorWolfgang Von Schütz
Diabeteszentrum für Kinder und Jugendliche, Kinderkrankenhaus auf der Bult, Janusz-Korczak-Allee, Hannover, Germany; and
Search for more papers by this authorKarin Lange
Department of Medical Psychology OE 5430, Hannover Medical School, Carl-Neuberg-Strasse, Hannover, Germany
Search for more papers by this authorClaudia Nestoris
Diabeteszentrum für Kinder und Jugendliche, Kinderkrankenhaus auf der Bult, Janusz-Korczak-Allee, Hannover, Germany; and
Search for more papers by this authorNicolin Datz
Diabeteszentrum für Kinder und Jugendliche, Kinderkrankenhaus auf der Bult, Janusz-Korczak-Allee, Hannover, Germany; and
Search for more papers by this authorOlga Kordonouri
Diabeteszentrum für Kinder und Jugendliche, Kinderkrankenhaus auf der Bult, Janusz-Korczak-Allee, Hannover, Germany; and
Search for more papers by this authorCorresponding Author
Thomas Danne
Diabeteszentrum für Kinder und Jugendliche, Kinderkrankenhaus auf der Bult, Janusz-Korczak-Allee, Hannover, Germany; and
*Thomas Danne, MD, Kinderkrankenhaus auf der Bult, Janusz-Korczak-Allee 12, D-30173, Hannover, Germany. Tel: +49-511-8115340; fax: +49-511-8115344; e-mail: [email protected]Search for more papers by this authorWolfgang Von Schütz
Diabeteszentrum für Kinder und Jugendliche, Kinderkrankenhaus auf der Bult, Janusz-Korczak-Allee, Hannover, Germany; and
Search for more papers by this authorKarin Lange
Department of Medical Psychology OE 5430, Hannover Medical School, Carl-Neuberg-Strasse, Hannover, Germany
Search for more papers by this authorClaudia Nestoris
Diabeteszentrum für Kinder und Jugendliche, Kinderkrankenhaus auf der Bult, Janusz-Korczak-Allee, Hannover, Germany; and
Search for more papers by this authorNicolin Datz
Diabeteszentrum für Kinder und Jugendliche, Kinderkrankenhaus auf der Bult, Janusz-Korczak-Allee, Hannover, Germany; and
Search for more papers by this authorOlga Kordonouri
Diabeteszentrum für Kinder und Jugendliche, Kinderkrankenhaus auf der Bult, Janusz-Korczak-Allee, Hannover, Germany; and
Search for more papers by this authorAbstract
Abstract: Increasing evidence points to the importance of achieving low blood glucose variability and also a low hemoglobin A1c (HbA1c) to prevent diabetic late complications. Continuous subcutaneous insulin infusion (CSII) is associated with lower blood glucose variability in children. Frequent indications for starting CSII in youth are recurrent hypoglycemia, need for increased flexibility, poor glycemic control, dawn phenomenon, or needle phobia. At our center, about one-third of all patients across all age groups are currently on CSII. Although the average glycemic control is not very different from those on multiple daily injections, fewer patients are seen in the segment of very high and very low HbA1c with CSII. Across centers, the ‘recipes’ tailoring CSII treatment to individual patients and cultures are based more on experience than on evidence. However, several typical pediatric features have been identified. Patterns of the hourly basal rate and prandial insulin requirements vary with age. While many adolescents have increased requirements at dawn and dusk, young children show increasing needs in the second half of the day. Low insulin requirements, particularly in neonates, may need insulin dilution. The selection of catheters and needles has to be appropriate for the age. The opportunity to have an electronic memory read-out of all entries and alarms offers new possibilities of therapeutic monitoring, particularly in those youth not keeping good logbooks. This feature can be helpful, if a trustful relationship between the diabetes team and the family is established.
References
- 1
Dorchy H.
Dorchy's recipes explaining the ‘Intriguing efficacy of Belgian conventional therapy’.
Diabetes Care
1994: 7: 458–460.
10.2337/diacare.17.5.458 Google Scholar
- 2 Tamborlane WV, Fredrickson LP, Ahern JH. Insulin pump therapy in childhood diabetes mellitus: guidelines for use. Treat Endocrinol 2003: 2: 11–21.
- 3 Bin-Abbas BS, Sakati NA, Raef H, Al-Ashwal AA. Continuous subcutaneous insulin infusion in type 1 diabetic Saudi children. A comparison with conventional insulin therapy. Saudi Med J 2005: 26: 918–922.
- 4 International Society for Pediatric and Adolescent Diabetes, International Diabetes Federation, World Health Organisation. In: Swift PGF, ed. Consensus Guidelines for the Management of Insulin-Dependent (Type I) Diabetes Mellitus (IDDM) in childhood and adolescence. Zeist, the Netherlands: Medforum, 2000.
- 5 Danne T, Weber B, Hartmann R, Enders I, Burger W, Hovener G. Long-term glycemic control has a nonlinear association to the frequency of background retinopathy in adolescents with diabetes. Follow-up of the Berlin Retinopathy Study. Diabetes Care 1994: 17: 1390–1396.
- 6 DCCT Study Group. The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the Diabetes Control and Complications Trial. Diabetes 1995: 44: 968–983.
- 7 DCCT Study Group. Implementation of treatment protocols in the Diabetes Control and Complications Trial. Diabetes Care 1995: 18: 361–376.
- 8 Pickup JC, Kidd J, Burmiston S, Yemane N. Determinants of glycemic control in type 1 diabetes during intensified therapy with multiple daily insulin injections or continuous subcutaneous insulin infusion: importance of blood glucose variability. Diabetes Metab Res Rev 2006 Epub Jan 3.
- 9 Jeha GS, Karaviti LP, Anderson B et al. Insulin pump therapy in preschool children with type 1 diabetes mellitus improves glycemic control and decreases glucose excursions and the risk of hypoglycemia. Diabetes Technol Ther 2005: 7: 876–884.
- 10 Weintrob N, Benzaquen H, Galatzer A et al. Comparison of continuous subcutaneous insulin infusion and multiple daily injection regimens in children with type 1 diabetes: a randomized open crossover trial. Pediatrics 2003: 112: 559–564.
- 11 Kordonouri O, Hartmann R, Lauterborn R, Barnekow C, Hoeffe J, Deiss D. Age-specific advantages of continuous subcutaneous insulin infusion as compared with multiple daily injections in pediatric patients: one-year follow-up comparison by matched-pair analysis. Diabetes Care 2003: 29: 133–134.
- 12 Boland EA, Grey M, Oesterle A, Fredrickson L, Tamborlane WV. Continuous subcutaneous insulin infusion. A new way to lower risk of severe hypoglycemia, improve metabolic control, and enhance coping in adolescents with type 1 diabetes. Diabetes Care 1999: 22: 1779–1784.
- 13 Maniatis AK, Klingensmith GJ, Slover RH, Mowry CJ, Chase HP. Continuous subcutaneous insulin infusion therapy for children and adolescents: an option for routine diabetes care. Pediatrics 2001: 107: 351–356.
- 14 Chase HP. Don't take away my pump! Switching to injections may cause problems. Diabetes Forecast 2005: 58: 55–56.
- 15 De Beaufort CE, Houtzagers CM, Bruining GJ et al. Continuous subcutaneous insulin infusion (CSII) versus conventional injection therapy in newly diagnosed diabetic children: two-year follow-up of a randomized, prospective trial. Diabet Med 1989: 6: 766–771.
- 16 Jarosz-Chobot PP, Battelino T, Kordonouri O et al. The PedPump survey: indication for CSII and number of daily boluses are associated with HbA1c in 1086 children with T1 DM from 17 countries. Pediatr Diabetes 2005: 6 (Suppl. 3): 14 (Abstract).
- 17 Pankowska E, Skorka A, Szypowska A, Lipka M. Memory of insulin pumps and their record as a source of information about insulin therapy in children and adolescents with type 1 diabetes. Diabetes Technol Ther 2005: 7: 308–314.
- 18 Kaufman FR, Halvorson M, Kim C, Pitukcheewanont P. Use of insulin pump therapy at nighttime only for children 7–10 years of age with type 1 diabetes. Diabetes Care 2000: 23: 579–582.
- 19 Heidtmann B, Holl RW. Insulinpumpentherapie bei kindern und jugendlichen. Übersicht zur entwicklung, erfolg und besonderheiten dieser therapieform. Therapieforum Diabetes 2003: 2: 3–9.
- 20 Hanaire-Broutin H, Schumicki DM, Hoogma R, Souhami E. Safety of insulin glulisine compared with insulin aspart administered by continuous subcutaneous insulin infusion (CSII). Diabetes 2004: 53: A4.
- 21 Sensstius J, Harboe E, Westermann H. The stability of Novolog (insulin aspart) is unaffected when stored for up to seven days in an insulin infusion pump. Diabetes 2005: 54 (Suppl. 1): A101 (Abstract).
- 22 Griffin ME, Feder A, Tamborlane WV. Lipoatrophy associated with lispro insulin in insulin pump therapy: an old complication, a new cause? Diabetes Care 2001: 24: 174.
- 23 Jorgensen D, Solbeck H, Harboe E. Dilution of Novolog (insulin aspart 100 U/ml) with NPH medium for small dose use in continuous subcutaneous insulin infusion does not affect in-vitro stability. Diabetes 2005: 54 (Suppl. 1): A102 (Abstract).
- 24 Bharucha T, Brown J, McDonnell C et al. Neonatal diabetes mellitus: insulin pump as an alternative management strategy. J Paediatr Child Health 2005: 41: 522–526.
- 25
Mortensen HB,
Robertson KJ,
Aanstoot HJ et al.
Insulin management and metabolic control of type 1 diabetes mellitus in childhood and adolescence in 18 countries. Hvidore Study Group on Childhood Diabetes.
Diabet Med
1998: 15: 752–759.
10.1002/(SICI)1096-9136(199809)15:9<752::AID-DIA678>3.0.CO;2-W CAS PubMed Web of Science® Google Scholar
- 26 Danne T, Battelino T, Kordonouri O et al. A cross-sectional international survey of continuous subcutaneous insulin infusion in 377 children and adolescents with type 1 diabetes mellitus from 10 countries. Pediatr Diabetes 2005: 6: 193–198.
- 27 Ludvigsson J, Hanas R. Continuous glucose monitoring improved metabolic control in pediatric patients with type 1 diabetes: a controlled crossover study Pediatrics. 2003: 111: 933–938.
- 28 Conrad SC, McGrath MT, Gitelman SE. Transition from multiple daily injections to continuous subcutaneous insulin infusion in type 1 diabetes mellitus. J Pediatr 2002: 140: 235–240.
- 29 Boland E, Ahern J, Tamborlane WV. Pumps in kids: basal requirements for excellent metabolic control. Diabetes 2002: 51 (Suppl. 2): A3 (Abstract).
- 30 Doyle EA, Weinzimer SA, Steffen AT, Ahern JA, Vincent M, Tamborlane WV. A randomized, prospective trial comparing the efficacy of continuous subcutaneous insulin infusion with multiple daily injections using insulin glargine. Diabetes Care 2004: 27: 1554–1558.
- 31 Alemzadeh R, Ellis JN, Holzum MK, Parton EA, Wyatt DT. Beneficial effects of continuous subcutaneous insulin infusion and flexible multiple daily insulin regimen using insulin glargine in type 1 diabetes. Pediatrics 2004: 114: e91–e95.
- 32 Schiaffini R, Ciampalini P, Spera S, Cappa M, Crino A. An observational study comparing continuous subcutaneous insulin infusion (CSII) and insulin glargine in children with type 1 diabetes. Diabetes Metab Res Rev 2005: 21: 347–352.
- 33 Garg SK, Walker AJ, Hoff HK, D'Souza AO, Gottlieb PA, Chase HP. Glycemic parameters with multiple daily injections using insulin glargine versus insulin pump. Diabetes Technol Ther 2004: 6: 9–15.
- 34 Waldron S, Hanas R, Palmvig B. How do we educate young people to balance carbohydrate intake with adjustments of insulin? Horm Res 2002: 57 (Suppl. 1): 62–65.
- 35 Kaufman FR, Halvorson M, Carpenter S. Use of a plastic insulin dosage guide to correct blood glucose levels out of the target range and for carbohydrate counting in subjects with type 1 diabetes. Diabetes Care 1999: 8: 1252–1257.
- 36 Glaser NS, Iden SB, Green-Burgeson D et al. Benefits of an insulin dosage calculation device for adolescents with type 1 diabetes mellitus. J Pediatr Endocrinol Metab 2004: 17: 1641–1651.
- 37 Danne T, Odendahl R, Naeke A et al. Postprandial insulin aspart is preferred to preprandial human insulin by parents of preschool children with type 1 diabetes. Diabetes 2005: 54 (Suppl. 1): A 665 (Abstract).
- 38 Burdick J, Chase HP, Slover RH et al. Missed insulin meal boluses and elevated hemoglobin A1c levels in children receiving insulin pump therapy. Pediatrics 2004: 113: e221–e224.
- 39 Danne T, Battelino T, Jarosz-Chobot P et al. and the Pedpump Study Group. The PedPump Study: a low percentage of basal insulin and more than five daily boluses are associated with better centralized HbA1c in 1041 children on CSII from 17 countries. Diabetes 2005: 54 (Suppl. 1): A 453 (Abstract).